JOLIEL Trademark

Trademark Overview


On Wednesday, January 20, 2016, a trademark application was filed for JOLIEL with the United States Patent and Trademark Office. The USPTO has given the JOLIEL trademark a serial number of 86881045. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 11, 2017. This trademark is owned by Glaxo Group Limited. The JOLIEL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Vaccines
joliel

General Information


Serial Number86881045
Word MarkJOLIEL
Filing DateWednesday, January 20, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 11, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 26, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, September 11, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 11, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 3, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 1, 2017EXTENSION 1 GRANTED
Wednesday, February 1, 2017EXTENSION 1 FILED
Wednesday, February 1, 2017TEAS EXTENSION RECEIVED
Tuesday, August 9, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 14, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 14, 2016PUBLISHED FOR OPPOSITION
Wednesday, May 25, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 11, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 5, 2016ASSIGNED TO EXAMINER
Tuesday, January 26, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 23, 2016NEW APPLICATION ENTERED IN TRAM